HYPOTENSIVE LIPID

Application 1346/KOLNP/2003 published 2006-03-24, filed 2003-10-20
New compositions for and methods of treating ocular hypertension provide for effective treatment of ocular hypertension often using reduced concentrations of active components. Such compositions include a timolol component and a hypotensive lipid component. The present compositions and methods are relatively straightforward, can be easily produced, for example, using conventional manufacturing techniques, and can be easily and conveniently practiced, for example, using application or administration techniques or methodologies which are substantially similar to those employed with prior compositions used to treat ocular hypertension. (FIG. - 1)

Applicant

ALLERGAN INC
2525 DUPONT DRIVE T2-7H IRVINE CA 96212 USA

Inventor

1. CHEN JUNE 2. WOODWARD DAVID F 3. KHARLAMB ALEXANDER B

International Info

Classification: A61JK 31/5575,A61P 27/06,
Publication Number: WO 02/096432 A3
Application Date: 2002-05-30

Priority Information

60/294,845 US 2001-05-31